[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fDXjE5fasJz5u7Q30H_Ncqzn1C60vi_UPPqPA0EnpIJM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":49,"rows":56},"Hennepin Healthcare Research Institute",[4],72,false,8,0,65275,5,47,[14,17,20,22,25,27,29,31],{"name":15,"count":16},"Acute Coronary Syndrome",7,{"name":18,"count":19},"Diabetes Mellitus",4,{"name":21,"count":19},"Acute Myocardial Infarction",{"name":23,"count":24},"Inflammation",3,{"name":26,"count":24},"Diabetes Mellitus, Type 2",{"name":28,"count":24},"Sedation",{"name":30,"count":24},"HIV Infection",{"name":32,"count":24},"Acute Respiratory Failure",[34,39,44],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05627596","Free Samples for Health","2025-05-28","Nicotine Patch, 14 Mg\u002F24 Hr Transdermal Film, Extended Release",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT07126795","Magnesium Sulfate in Pediatric Burn Dressing Changes","2026-12-01","magnesium sulfate",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06514547","Vaccine Immunity and Inflammation in the Aging Person Living With HIV","2028-09-15","Conjugate Pneumococcal Vaccine 20",[50,51,52,53,54,55],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[57,82,106,124,148,166,235,278,301,326,350,368,386,412,438,456,474,492,518,543,568,594,612,660,682,704,733,759,777,804,822,847,865],{"intervention":48,"totalTrials":58,"cells":59},1,{"EARLY_PHASE1":60,"PHASE1":62,"PHASE2":64,"PHASE3":66,"PHASE4":68,"NA":80},{"trials":61,"activeCount":9},[],{"trials":63,"activeCount":9},[],{"trials":65,"activeCount":9},[],{"trials":67,"activeCount":9},[],{"trials":69,"activeCount":58,"soonestReadout":47},[70],{"nctId":45,"briefTitle":46,"status":71,"phases":72,"primaryCompletion":47,"completion":73,"start":74,"enrollment":75,"conditions":76,"interventions":79},"RECRUITING",[54],"2029-06-30","2024-07-08",250,[77,78],"HIV Infections","Age",[48],{"trials":81,"activeCount":9},[],{"intervention":38,"totalTrials":58,"cells":83},{"EARLY_PHASE1":84,"PHASE1":86,"PHASE2":88,"PHASE3":100,"PHASE4":102,"NA":104},{"trials":85,"activeCount":9},[],{"trials":87,"activeCount":9},[],{"trials":89,"activeCount":58,"soonestReadout":37},[90],{"nctId":35,"briefTitle":36,"status":91,"phases":92,"primaryCompletion":37,"completion":93,"start":94,"enrollment":95,"conditions":96,"interventions":98},"ENROLLING_BY_INVITATION",[52],"2025-07-31","2023-06-12",1200,[97],"Cigarette Smoking",[38,99],"Nicotine lozenge",{"trials":101,"activeCount":9},[],{"trials":103,"activeCount":9},[],{"trials":105,"activeCount":9},[],{"intervention":99,"totalTrials":58,"cells":107},{"EARLY_PHASE1":108,"PHASE1":110,"PHASE2":112,"PHASE3":118,"PHASE4":120,"NA":122},{"trials":109,"activeCount":9},[],{"trials":111,"activeCount":9},[],{"trials":113,"activeCount":58,"soonestReadout":37},[114],{"nctId":35,"briefTitle":36,"status":91,"phases":115,"primaryCompletion":37,"completion":93,"start":94,"enrollment":95,"conditions":116,"interventions":117},[52],[97],[38,99],{"trials":119,"activeCount":9},[],{"trials":121,"activeCount":9},[],{"trials":123,"activeCount":9},[],{"intervention":43,"totalTrials":58,"cells":125},{"EARLY_PHASE1":126,"PHASE1":128,"PHASE2":140,"PHASE3":142,"PHASE4":144,"NA":146},{"trials":127,"activeCount":9},[],{"trials":129,"activeCount":58,"soonestReadout":42},[130],{"nctId":40,"briefTitle":41,"status":131,"phases":132,"primaryCompletion":42,"completion":133,"start":134,"enrollment":135,"conditions":136,"interventions":138},"NOT_YET_RECRUITING",[51],"2027-01-01","2026-01-01",10,[137],"Pediatric Burns",[43,139],"Normal Saline",{"trials":141,"activeCount":9},[],{"trials":143,"activeCount":9},[],{"trials":145,"activeCount":9},[],{"trials":147,"activeCount":9},[],{"intervention":139,"totalTrials":58,"cells":149},{"EARLY_PHASE1":150,"PHASE1":152,"PHASE2":158,"PHASE3":160,"PHASE4":162,"NA":164},{"trials":151,"activeCount":9},[],{"trials":153,"activeCount":58,"soonestReadout":42},[154],{"nctId":40,"briefTitle":41,"status":131,"phases":155,"primaryCompletion":42,"completion":133,"start":134,"enrollment":135,"conditions":156,"interventions":157},[51],[137],[43,139],{"trials":159,"activeCount":9},[],{"trials":161,"activeCount":9},[],{"trials":163,"activeCount":9},[],{"trials":165,"activeCount":9},[],{"intervention":167,"totalTrials":11,"cells":168},"propofol",{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":175,"PHASE4":177,"NA":233},{"trials":170,"activeCount":9},[],{"trials":172,"activeCount":9},[],{"trials":174,"activeCount":9},[],{"trials":176,"activeCount":9},[],{"trials":178,"activeCount":9},[179,191,202,215,224],{"nctId":180,"briefTitle":181,"status":182,"phases":183,"primaryCompletion":184,"completion":185,"start":186,"enrollment":187,"conditions":188,"interventions":190},"NCT02404610","Moderate Versus Deep Procedural Sedation With Propofol in the Emergency Department","COMPLETED",[54],"2018-10-01","2018-12-01","2014-07",107,[189],"Pain",[167],{"nctId":192,"briefTitle":193,"status":182,"phases":194,"primaryCompletion":195,"completion":196,"start":197,"enrollment":198,"conditions":199,"interventions":200},"NCT00997113","Stress During Deep Sedation With Propofol With and Without Alfentanil",[54],"2012-10","2012-12","2009-10",20,[28],[167,201],"alfentanil",{"nctId":203,"briefTitle":204,"status":182,"phases":205,"primaryCompletion":206,"completion":206,"start":207,"enrollment":208,"conditions":209,"interventions":211},"NCT01260662","Randomized Clinical Trial of Propofol, 1:1 and 4:1 Combination of Propofol and Ketamine for Procedural Sedation",[54],"2013-08","2010-11",271,[210],"Procedural Sedation",[212,213,214],"Propofol","1:1 Propofol\u002FKetamine","4:1 Propofol\u002FKetamine",{"nctId":216,"briefTitle":217,"status":182,"phases":218,"primaryCompletion":219,"completion":219,"start":197,"enrollment":220,"conditions":221,"interventions":222},"NCT00997126","Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation",[54],"2015-04",126,[28],[212,223],"Alfentanil",{"nctId":225,"briefTitle":226,"status":182,"phases":227,"primaryCompletion":197,"completion":197,"start":228,"enrollment":229,"conditions":230,"interventions":231},"NCT00997321","Propofol Versus Ketamine for Moderate Procedural Sedation in the Emergency Department (ED)",[54],"2007-07",100,[28],[167,232],"Ketamine",{"trials":234,"activeCount":9},[],{"intervention":232,"totalTrials":24,"cells":236},{"EARLY_PHASE1":237,"PHASE1":239,"PHASE2":241,"PHASE3":243,"PHASE4":245,"NA":276},{"trials":238,"activeCount":9},[],{"trials":240,"activeCount":9},[],{"trials":242,"activeCount":9},[],{"trials":244,"activeCount":9},[],{"trials":246,"activeCount":9},[247,261,265],{"nctId":248,"briefTitle":249,"status":182,"phases":250,"primaryCompletion":251,"completion":251,"start":252,"enrollment":253,"conditions":254,"interventions":259},"NCT01823328","Ketamine Versus Etomidate for Rapid Sequence Intubation",[54],"2015-10","2013-09",143,[255,256,257,258],"Airway Control","Anesthesia","Intubation","Complication",[232,260],"Etomidate",{"nctId":225,"briefTitle":226,"status":182,"phases":262,"primaryCompletion":197,"completion":197,"start":228,"enrollment":229,"conditions":263,"interventions":264},[54],[28],[167,232],{"nctId":266,"briefTitle":267,"status":268,"phases":269,"primaryCompletion":270,"completion":270,"start":271,"enrollment":9,"conditions":272,"interventions":274},"NCT02103881","Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital","WITHDRAWN",[54],"2014-06","2014-04",[273],"Agitation",[232,275],"Haloperidol",{"trials":277,"activeCount":9},[],{"intervention":201,"totalTrials":279,"cells":280},2,{"EARLY_PHASE1":281,"PHASE1":283,"PHASE2":285,"PHASE3":287,"PHASE4":289,"NA":299},{"trials":282,"activeCount":9},[],{"trials":284,"activeCount":9},[],{"trials":286,"activeCount":9},[],{"trials":288,"activeCount":9},[],{"trials":290,"activeCount":9},[291,295],{"nctId":192,"briefTitle":193,"status":182,"phases":292,"primaryCompletion":195,"completion":196,"start":197,"enrollment":198,"conditions":293,"interventions":294},[54],[28],[167,201],{"nctId":216,"briefTitle":217,"status":182,"phases":296,"primaryCompletion":219,"completion":219,"start":197,"enrollment":220,"conditions":297,"interventions":298},[54],[28],[212,223],{"trials":300,"activeCount":9},[],{"intervention":302,"totalTrials":58,"cells":303},"Tenofovir disoproxil",{"EARLY_PHASE1":304,"PHASE1":306,"PHASE2":308,"PHASE3":310,"PHASE4":312,"NA":324},{"trials":305,"activeCount":9},[],{"trials":307,"activeCount":9},[],{"trials":309,"activeCount":9},[],{"trials":311,"activeCount":9},[],{"trials":313,"activeCount":9},[314],{"nctId":315,"briefTitle":316,"status":317,"phases":318,"primaryCompletion":319,"completion":320,"start":197,"enrollment":321,"conditions":322,"interventions":323},"NCT00998582","Artery Elasticity After Switch From Epzicom to Truvada","TERMINATED",[54],"2011-06","2011-12",27,[77],[302],{"trials":325,"activeCount":9},[],{"intervention":327,"totalTrials":58,"cells":328},"NPH",{"EARLY_PHASE1":329,"PHASE1":331,"PHASE2":333,"PHASE3":335,"PHASE4":337,"NA":348},{"trials":330,"activeCount":9},[],{"trials":332,"activeCount":9},[],{"trials":334,"activeCount":9},[],{"trials":336,"activeCount":9},[],{"trials":338,"activeCount":9},[339],{"nctId":340,"briefTitle":341,"status":182,"phases":342,"primaryCompletion":343,"completion":343,"start":186,"enrollment":344,"conditions":345,"interventions":346},"NCT01970241","Inpatient Diabetes on Corticosteroids",[54],"2016-06",85,[18],[327,347],"Correction Factor",{"trials":349,"activeCount":9},[],{"intervention":347,"totalTrials":58,"cells":351},{"EARLY_PHASE1":352,"PHASE1":354,"PHASE2":356,"PHASE3":358,"PHASE4":360,"NA":366},{"trials":353,"activeCount":9},[],{"trials":355,"activeCount":9},[],{"trials":357,"activeCount":9},[],{"trials":359,"activeCount":9},[],{"trials":361,"activeCount":9},[362],{"nctId":340,"briefTitle":341,"status":182,"phases":363,"primaryCompletion":343,"completion":343,"start":186,"enrollment":344,"conditions":364,"interventions":365},[54],[18],[327,347],{"trials":367,"activeCount":9},[],{"intervention":260,"totalTrials":58,"cells":369},{"EARLY_PHASE1":370,"PHASE1":372,"PHASE2":374,"PHASE3":376,"PHASE4":378,"NA":384},{"trials":371,"activeCount":9},[],{"trials":373,"activeCount":9},[],{"trials":375,"activeCount":9},[],{"trials":377,"activeCount":9},[],{"trials":379,"activeCount":9},[380],{"nctId":248,"briefTitle":249,"status":182,"phases":381,"primaryCompletion":251,"completion":251,"start":252,"enrollment":253,"conditions":382,"interventions":383},[54],[255,256,257,258],[232,260],{"trials":385,"activeCount":9},[],{"intervention":387,"totalTrials":58,"cells":388},"Enoxaparin",{"EARLY_PHASE1":389,"PHASE1":391,"PHASE2":393,"PHASE3":395,"PHASE4":397,"NA":410},{"trials":390,"activeCount":9},[],{"trials":392,"activeCount":9},[],{"trials":394,"activeCount":9},[],{"trials":396,"activeCount":9},[],{"trials":398,"activeCount":9},[399],{"nctId":400,"briefTitle":401,"status":182,"phases":402,"completion":403,"start":404,"enrollment":405,"conditions":406,"interventions":409},"NCT00170378","The Use of Low Molecular Weight Heparin in Traumatic Brain Injury",[54],"2005-08","2002-12",300,[407,408],"Brain Injury","Venous Thrombosis",[387],{"trials":411,"activeCount":9},[],{"intervention":413,"totalTrials":58,"cells":414},"Lidocaine Iv",{"EARLY_PHASE1":415,"PHASE1":417,"PHASE2":419,"PHASE3":421,"PHASE4":423,"NA":436},{"trials":416,"activeCount":9},[],{"trials":418,"activeCount":9},[],{"trials":420,"activeCount":9},[],{"trials":422,"activeCount":9},[],{"trials":424,"activeCount":9},[425],{"nctId":426,"briefTitle":427,"status":317,"phases":428,"primaryCompletion":429,"completion":429,"start":430,"enrollment":19,"conditions":431,"interventions":434},"NCT04398316","High Dose IV Lidocaine vs Hydromorphone for Abdominal Pain in the Emergency Department",[54],"2021-06-30","2021-02-18",[432,433],"Abdominal Pain","Renal Colic",[413,435],"HYDROmorphone",{"trials":437,"activeCount":9},[],{"intervention":435,"totalTrials":58,"cells":439},{"EARLY_PHASE1":440,"PHASE1":442,"PHASE2":444,"PHASE3":446,"PHASE4":448,"NA":454},{"trials":441,"activeCount":9},[],{"trials":443,"activeCount":9},[],{"trials":445,"activeCount":9},[],{"trials":447,"activeCount":9},[],{"trials":449,"activeCount":9},[450],{"nctId":426,"briefTitle":427,"status":317,"phases":451,"primaryCompletion":429,"completion":429,"start":430,"enrollment":19,"conditions":452,"interventions":453},[54],[432,433],[413,435],{"trials":455,"activeCount":9},[],{"intervention":213,"totalTrials":58,"cells":457},{"EARLY_PHASE1":458,"PHASE1":460,"PHASE2":462,"PHASE3":464,"PHASE4":466,"NA":472},{"trials":459,"activeCount":9},[],{"trials":461,"activeCount":9},[],{"trials":463,"activeCount":9},[],{"trials":465,"activeCount":9},[],{"trials":467,"activeCount":9},[468],{"nctId":203,"briefTitle":204,"status":182,"phases":469,"primaryCompletion":206,"completion":206,"start":207,"enrollment":208,"conditions":470,"interventions":471},[54],[210],[212,213,214],{"trials":473,"activeCount":9},[],{"intervention":214,"totalTrials":58,"cells":475},{"EARLY_PHASE1":476,"PHASE1":478,"PHASE2":480,"PHASE3":482,"PHASE4":484,"NA":490},{"trials":477,"activeCount":9},[],{"trials":479,"activeCount":9},[],{"trials":481,"activeCount":9},[],{"trials":483,"activeCount":9},[],{"trials":485,"activeCount":9},[486],{"nctId":203,"briefTitle":204,"status":182,"phases":487,"primaryCompletion":206,"completion":206,"start":207,"enrollment":208,"conditions":488,"interventions":489},[54],[210],[212,213,214],{"trials":491,"activeCount":9},[],{"intervention":493,"totalTrials":58,"cells":494},"Aspirin",{"EARLY_PHASE1":495,"PHASE1":497,"PHASE2":499,"PHASE3":501,"PHASE4":503,"NA":516},{"trials":496,"activeCount":9},[],{"trials":498,"activeCount":9},[],{"trials":500,"activeCount":9},[],{"trials":502,"activeCount":9},[],{"trials":504,"activeCount":9},[505],{"nctId":506,"briefTitle":507,"status":508,"phases":509,"primaryCompletion":510,"completion":511,"start":252,"enrollment":512,"conditions":513,"interventions":515},"NCT01968798","ASPREE Cancer Endpoints Study","UNKNOWN",[54],"2019-01","2024-04",14500,[514],"Cancer",[493],{"trials":517,"activeCount":9},[],{"intervention":519,"totalTrials":58,"cells":520},"Losartan 100mg daily",{"EARLY_PHASE1":521,"PHASE1":523,"PHASE2":525,"PHASE3":537,"PHASE4":539,"NA":541},{"trials":522,"activeCount":9},[],{"trials":524,"activeCount":9},[],{"trials":526,"activeCount":9},[527],{"nctId":528,"briefTitle":529,"status":182,"phases":530,"primaryCompletion":531,"completion":531,"start":532,"enrollment":533,"conditions":534,"interventions":536},"NCT02049307","Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial",[52],"2018-12-14","2014-10-16",108,[23,535],"Fibrosis",[519],{"trials":538,"activeCount":9},[],{"trials":540,"activeCount":9},[],{"trials":542,"activeCount":9},[],{"intervention":544,"totalTrials":58,"cells":545},"Edoxaban 30mg daily",{"EARLY_PHASE1":546,"PHASE1":548,"PHASE2":550,"PHASE3":562,"PHASE4":564,"NA":566},{"trials":547,"activeCount":9},[],{"trials":549,"activeCount":9},[],{"trials":551,"activeCount":9},[552],{"nctId":553,"briefTitle":554,"status":182,"phases":555,"primaryCompletion":556,"completion":556,"start":557,"enrollment":558,"conditions":559,"interventions":561},"NCT02339415","Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease",[52],"2018-09","2015-07",44,[23,560,30],"Coagulation",[544],{"trials":563,"activeCount":9},[],{"trials":565,"activeCount":9},[],{"trials":567,"activeCount":9},[],{"intervention":569,"totalTrials":58,"cells":570},"Aspirin 325mg",{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":588,"PHASE4":590,"NA":592},{"trials":572,"activeCount":9},[],{"trials":574,"activeCount":9},[],{"trials":576,"activeCount":9},[577],{"nctId":578,"briefTitle":579,"status":317,"phases":580,"primaryCompletion":581,"completion":582,"start":583,"enrollment":584,"conditions":585,"interventions":586},"NCT00783614","Aspirin and Antiretroviral Therapy in HIV Infected Patients",[52],"2010-01","2010-06","2008-10",22,[30],[569,587],"Antiretroviral therapy",{"trials":589,"activeCount":9},[],{"trials":591,"activeCount":9},[],{"trials":593,"activeCount":9},[],{"intervention":587,"totalTrials":58,"cells":595},{"EARLY_PHASE1":596,"PHASE1":598,"PHASE2":600,"PHASE3":606,"PHASE4":608,"NA":610},{"trials":597,"activeCount":9},[],{"trials":599,"activeCount":9},[],{"trials":601,"activeCount":9},[602],{"nctId":578,"briefTitle":579,"status":317,"phases":603,"primaryCompletion":581,"completion":582,"start":583,"enrollment":584,"conditions":604,"interventions":605},[52],[30],[569,587],{"trials":607,"activeCount":9},[],{"trials":609,"activeCount":9},[],{"trials":611,"activeCount":9},[],{"intervention":613,"totalTrials":24,"cells":614},"Olanzapine",{"EARLY_PHASE1":615,"PHASE1":617,"PHASE2":619,"PHASE3":621,"PHASE4":623,"NA":625},{"trials":616,"activeCount":9},[],{"trials":618,"activeCount":9},[],{"trials":620,"activeCount":9},[],{"trials":622,"activeCount":9},[],{"trials":624,"activeCount":9},[],{"trials":626,"activeCount":9},[627,640,649],{"nctId":628,"briefTitle":629,"status":182,"phases":630,"primaryCompletion":631,"completion":631,"start":632,"enrollment":633,"conditions":634,"interventions":636},"NCT03211897","Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation",[],"2017-10-01","2017-06-15",737,[635],"Agitation,Psychomotor",[275,637,638,639],"Ziprasidone","OLANZapine","Midazolam",{"nctId":641,"briefTitle":642,"status":317,"phases":643,"primaryCompletion":644,"completion":644,"start":645,"enrollment":646,"conditions":647,"interventions":648},"NCT03899506","Olanzapine Versus Midazolam for Agitation",[],"2018-07-16","2018-06-18",206,[635],[613,639],{"nctId":650,"briefTitle":651,"status":182,"phases":652,"primaryCompletion":653,"completion":653,"start":654,"enrollment":655,"conditions":656,"interventions":658},"NCT02643355","Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED",[55],"2017-06-21","2015-11",70,[657],"Substance Withdrawal Syndrome",[613,659],"Clonidine",{"intervention":275,"totalTrials":279,"cells":661},{"EARLY_PHASE1":662,"PHASE1":664,"PHASE2":666,"PHASE3":668,"PHASE4":670,"NA":676},{"trials":663,"activeCount":9},[],{"trials":665,"activeCount":9},[],{"trials":667,"activeCount":9},[],{"trials":669,"activeCount":9},[],{"trials":671,"activeCount":9},[672],{"nctId":266,"briefTitle":267,"status":268,"phases":673,"primaryCompletion":270,"completion":270,"start":271,"enrollment":9,"conditions":674,"interventions":675},[54],[273],[232,275],{"trials":677,"activeCount":9},[678],{"nctId":628,"briefTitle":629,"status":182,"phases":679,"primaryCompletion":631,"completion":631,"start":632,"enrollment":633,"conditions":680,"interventions":681},[],[635],[275,637,638,639],{"intervention":639,"totalTrials":279,"cells":683},{"EARLY_PHASE1":684,"PHASE1":686,"PHASE2":688,"PHASE3":690,"PHASE4":692,"NA":694},{"trials":685,"activeCount":9},[],{"trials":687,"activeCount":9},[],{"trials":689,"activeCount":9},[],{"trials":691,"activeCount":9},[],{"trials":693,"activeCount":9},[],{"trials":695,"activeCount":9},[696,700],{"nctId":628,"briefTitle":629,"status":182,"phases":697,"primaryCompletion":631,"completion":631,"start":632,"enrollment":633,"conditions":698,"interventions":699},[],[635],[275,637,638,639],{"nctId":641,"briefTitle":642,"status":317,"phases":701,"primaryCompletion":644,"completion":644,"start":645,"enrollment":646,"conditions":702,"interventions":703},[],[635],[613,639],{"intervention":705,"totalTrials":58,"cells":706},"100 mg enteric-coated aspirin",{"EARLY_PHASE1":707,"PHASE1":709,"PHASE2":711,"PHASE3":713,"PHASE4":715,"NA":717},{"trials":708,"activeCount":9},[],{"trials":710,"activeCount":9},[],{"trials":712,"activeCount":9},[],{"trials":714,"activeCount":9},[],{"trials":716,"activeCount":9},[],{"trials":718,"activeCount":9},[719],{"nctId":720,"briefTitle":721,"status":508,"phases":722,"primaryCompletion":723,"completion":511,"start":581,"enrollment":724,"conditions":725,"interventions":732},"NCT01038583","Aspirin in Reducing Events in the Elderly",[],"2017-12",19114,[726,727,728,729,514,730,731],"Functional Disability","Dementia","Heart Disease","Stroke","Bleeding","Depression",[705],{"intervention":734,"totalTrials":58,"cells":735},"Nicotine Replacement Therapy",{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":740,"PHASE3":742,"PHASE4":744,"NA":746},{"trials":737,"activeCount":9},[],{"trials":739,"activeCount":9},[],{"trials":741,"activeCount":9},[],{"trials":743,"activeCount":9},[],{"trials":745,"activeCount":9},[],{"trials":747,"activeCount":9},[748],{"nctId":749,"briefTitle":750,"status":182,"phases":751,"primaryCompletion":752,"completion":753,"start":754,"enrollment":755,"conditions":756,"interventions":758},"NCT03799315","Jail-Based Use of Smoking Cessation Treatment Study",[55],"2020-03-16","2020-08-29","2019-01-14",66,[757],"Tobacco Use",[734],{"intervention":637,"totalTrials":58,"cells":760},{"EARLY_PHASE1":761,"PHASE1":763,"PHASE2":765,"PHASE3":767,"PHASE4":769,"NA":771},{"trials":762,"activeCount":9},[],{"trials":764,"activeCount":9},[],{"trials":766,"activeCount":9},[],{"trials":768,"activeCount":9},[],{"trials":770,"activeCount":9},[],{"trials":772,"activeCount":9},[773],{"nctId":628,"briefTitle":629,"status":182,"phases":774,"primaryCompletion":631,"completion":631,"start":632,"enrollment":633,"conditions":775,"interventions":776},[],[635],[275,637,638,639],{"intervention":778,"totalTrials":58,"cells":779},"Pravastatin",{"EARLY_PHASE1":780,"PHASE1":782,"PHASE2":784,"PHASE3":786,"PHASE4":788,"NA":790},{"trials":781,"activeCount":9},[],{"trials":783,"activeCount":9},[],{"trials":785,"activeCount":9},[],{"trials":787,"activeCount":9},[],{"trials":789,"activeCount":9},[],{"trials":791,"activeCount":9},[792],{"nctId":793,"briefTitle":794,"status":182,"phases":795,"primaryCompletion":796,"completion":797,"start":798,"enrollment":799,"conditions":800,"interventions":802},"NCT00982189","Cardiovascular Prevention for Persons With HIV",[55],"2010-12","2011-05","2009-09",37,[30,801],"Cardiovascular Disease Risk",[778,803],"Lisinopril",{"intervention":803,"totalTrials":58,"cells":805},{"EARLY_PHASE1":806,"PHASE1":808,"PHASE2":810,"PHASE3":812,"PHASE4":814,"NA":816},{"trials":807,"activeCount":9},[],{"trials":809,"activeCount":9},[],{"trials":811,"activeCount":9},[],{"trials":813,"activeCount":9},[],{"trials":815,"activeCount":9},[],{"trials":817,"activeCount":9},[818],{"nctId":793,"briefTitle":794,"status":182,"phases":819,"primaryCompletion":796,"completion":797,"start":798,"enrollment":799,"conditions":820,"interventions":821},[55],[30,801],[778,803],{"intervention":823,"totalTrials":58,"cells":824},"Degludec",{"EARLY_PHASE1":825,"PHASE1":827,"PHASE2":829,"PHASE3":831,"PHASE4":833,"NA":835},{"trials":826,"activeCount":9},[],{"trials":828,"activeCount":9},[],{"trials":830,"activeCount":9},[],{"trials":832,"activeCount":9},[],{"trials":834,"activeCount":9},[],{"trials":836,"activeCount":9},[837],{"nctId":838,"briefTitle":839,"status":317,"phases":840,"primaryCompletion":841,"completion":842,"start":843,"enrollment":321,"conditions":844,"interventions":845},"NCT03001323","Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis",[55],"2019-01-20","2020-09-25","2017-01",[18],[823,846],"Standard long-acting",{"intervention":846,"totalTrials":58,"cells":848},{"EARLY_PHASE1":849,"PHASE1":851,"PHASE2":853,"PHASE3":855,"PHASE4":857,"NA":859},{"trials":850,"activeCount":9},[],{"trials":852,"activeCount":9},[],{"trials":854,"activeCount":9},[],{"trials":856,"activeCount":9},[],{"trials":858,"activeCount":9},[],{"trials":860,"activeCount":9},[861],{"nctId":838,"briefTitle":839,"status":317,"phases":862,"primaryCompletion":841,"completion":842,"start":843,"enrollment":321,"conditions":863,"interventions":864},[55],[18],[823,846],{"intervention":659,"totalTrials":58,"cells":866},{"EARLY_PHASE1":867,"PHASE1":869,"PHASE2":871,"PHASE3":873,"PHASE4":875,"NA":877},{"trials":868,"activeCount":9},[],{"trials":870,"activeCount":9},[],{"trials":872,"activeCount":9},[],{"trials":874,"activeCount":9},[],{"trials":876,"activeCount":9},[],{"trials":878,"activeCount":9},[879],{"nctId":650,"briefTitle":651,"status":182,"phases":880,"primaryCompletion":653,"completion":653,"start":654,"enrollment":655,"conditions":881,"interventions":882},[55],[657],[613,659]]